Meifang Li

Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma

Cheng Lin, Xiong Chen, Meifang Li et al. · Clinical Lung Cancer · 2015 · 124 citations

Medicine, Cancer Biology, Oncology +14

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Sanfang Tu, Xuan Zhou, Zhenling Guo et al. · Frontiers in Oncology · 2019 · 79 citations · Full text

Medicine, Hematology, Oncology +14

The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells

Haiying Wang, Qian Li, Shusen Tang et al. · Hematology · 2016 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +17

Au@MnS@ZnS Core/Shell/Shell Nanoparticles for Magnetic Resonance Imaging and Enhanced Cancer Radiation Therapy

Meifang Li, Qi Zhao, Xuan Yi et al. · ACS Applied Materials & Interfaces · 2016 · 77 citations

Medicine, Oncology, Radiation Oncology +17

The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes

Meifang Li, Cui-Chun Zhao, Tingting Li et al. · Cardiovascular Diabetology · 2016 · 62 citations · Full text

Medicine, Internal Medicine, Clinical Cardiology +14